Tecentriq Market expansion is supported by the growing use of immunotherapy in lung cancer treatment. Atezolizumab is used in specific cases of non-small cell lung cancer and small cell lung cancer, either alone or in combination with other medicines, depending on the indication. The Tecentriq Market size is projected to reach US$ 12.55 million by 2034 from US$ 4.29 million in 2025. The market...